Feraheme FDA Approval History
FDA Approved: Yes (First approved June 30, 2009)
Brand name: Feraheme
Generic name: ferumoxytol
Dosage form: Intravenous Injection
Company: AMAG Pharmaceuticals, Inc.
Treatment for: Anemia Due to Chronic Kidney Disease, Iron Deficiency Anemia
Feraheme (ferumoxytol) is an iron replacement therapy for the treatment of iron deficiency anemia in adult patients.
Development timeline for Feraheme
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.